Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. . Lancet 2021;397:1637-1645.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021;397:1637-1645.
PMID: 33933206